黄体期对比卵泡期卵巢切除术他莫昔芬用于
2017-6-25 来源:本站原创 浏览次数:次年4月20日,欧洲癌症研究与治疗组织(EORTC)、欧洲癌症组织(ECCO)、欧洲癌症研究学会(EACR)、欧洲乳腺癌专家学会(EUSOMA)官方期刊《欧洲癌症杂志》(EJC)在线发表了美国(国际乳腺癌研究基金会、俄亥俄州立大学)、中国(医院、医院、医院医院、中国医学科学院北医院、医院、首都医科医院、国立台医院)、孟加拉国(医院、医院、国医院、邦格班杜·谢赫·穆吉医院、阿马德·格兰乳腺癌中心)、菲律宾(医院、维森特·医院、黎刹医学中心、医院)、尼日利亚(医院)、印度尼西亚(医院)、马来西亚(马来亚大学医学中心)的随机对照研究,发现:
卵巢切除术+他莫昔芬对于条件受限患者是有效的治疗方法
卵泡期长的月经周期史不准确
卵泡期长的患者卵巢切除术生存较差
某些患者存在围手术期不良反应
根据月经周期史决定卵巢切除术时机不影响转移性患者结局
EurJCancer.;60:-.
Lutealversusfollicularphasesurgicaloophorectomyplustamoxifeninpremenopausalwomenwithmetastatichormonereceptor-positivebreastcancer.
LoveRR,HossainSM,HussainMM,MostafaMG,LaudicoAV,SiguanSS,AdebamowoC,SunJZ,FeiF,ShaoZM,LiuY,AkramHussainSM,ZhangB,ChengL,PanigaroS,WaltaF,ChuanJH,Mirasol-LumagueMR,YipCH,NavarroNSJr,HuangCS,LuYS,FerdousyT,SalimR,AkhterC,NaharS,UyG,YoungGS,HadeEM,JarjouraD.
TheInternationalBreastCancerResearchFoundation,USA.
KhulnaMedicalCollegeandHospital,Khulna,Bangladesh.
DhakaMedicalCollegeandHospital,Dhaka,Bangladesh.
NationalCancerResearchInstituteandHospital,Dhaka,Bangladesh.
PhilippinesGeneralHospital,Manila,Philippines.
VicenteSottoMemorialHospital,Cebu,Philippines.
UniversityCollegeHospital,Ibadan,Nigeria.
QiluHospital,Jinan,China.
CancerInstitute,FudanUniversity,Shanghai,China.
4thHospital,Hebei,China.
BSMMUPostgraduateHospital,Dhaka,Bangladesh.
CancerInstituteandHospital,ChineseAcademyofMedicalSciencesandPekingUnionMedicalCollege,Beijing,China.
PeoplesHospital,Beijing,China.
UniversityofIndonesiaGeneralHospital,Jakarta,Indonesia.
ChaoYangHospital,Beijing,China.
RizalMedicalCenter,PasigCity,Philippines.
UniversityofMalayaMedicalCenter,KualaLumpur,Malaysia.
SantoThomasUniversityHospital,Manila,Philippines.
NationalTaiwanUniversityHospital,Taipei,Taiwan.
AmaderGram,Khulna,Bangladesh.
TheOhioStateUniversityCenterforBiostatistics,Columbus,Ohio,USA.
Highlights
Surgicaloophorectomy+tamoxifenisgoodtherapyinpatientswithlimitedresources.
Menstrualcyclehistoriesareinaccuratebecauseoflongfollicularphases.
Patientswithlongfollicularphasestendtohavepoorersurvivalwithoophorectomy.
Withotherdata,thisstudysuggestsperi-operativeadverseeffectsinsomepatients.
PURPOSE:Inpremenopausalwomenwithmetastatichormonereceptor-positivebreastcancer,hormonaltherapyisthefirst-linetherapy.Gonadotropin-releasinghormoneanalogue+tamoxifentherapieshavebeenfoundtobemoreeffective.Thepatternofrecurrenceriskovertimeafterprimarysurgerysuggeststhatperi-operativefactorsimpactrecurrence.Secondaryanalysesofanadjuvanttrialsuggestedthatthelutealphasetimingofsurgicaloophorectomyinthemenstrualcyclesimultaneouswithprimarybreastsurgeryfavourablyinfluencedlong-termout北京治疗白癜风比较好的医院北京治疗白癜风医院哪个比较好